Sera Prognostics (SERA) Research & Development (2020 - 2026)
Sera Prognostics (SERA) posted Research & Development of $3.0 million for Q1 2026, up 81.98% on a QoQ basis from $1.7 million in Q4 2025, and up 106.12% year-over-year from $1.5 million in Q1 2025.
Sera Prognostics (SERA) Research & Development (2020 - 2026) Analysis & Trends
Sera Prognostics' Research & Development history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Research & Development rose 106.12% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 46.39% YoY) and the FY2025 annual result came in at $6.5 million, down 55.55% from the prior year.
- Research & Development was $3.0 million for Q1 2026 at Sera Prognostics, up from $1.7 million in the prior quarter.
- Across five years, Research & Development topped out at $11.2 million in Q4 2024 and bottomed at $1.2 million in Q3 2024.
- A 5-year average of $3.3 million and a median of $3.1 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development jumped 188.14% — and 2025, when it tumbled 85.16%.
- Sera Prognostics' Research & Development stood at $3.1 million in 2022, then gained by 27.5% to $3.9 million in 2023, then jumped by 188.14% to $11.2 million in 2024, then tumbled by 85.16% to $1.7 million in 2025, then surged by 81.98% to $3.0 million in 2026.
- Business Quant data shows SERA's Research & Development at $3.0 million in Q1 2026, $1.7 million in Q4 2025, and $3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 145.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | 345.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | -461.27 Mn |
| 10 | Sera Prognostics | 102.28 Mn | 102.28 Mn | -28,000.00 | 3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 11.22 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 2.87 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Dec 31, 2021 | 5.24 Mn |
| Sep 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | 1.74 Mn |